Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market (2025-2031) | Trends, Share, Value, Competitive Landscape, Industry, Analysis, Segmentation, Size & Revenue, Growth, Outlook, Companies, Forecast

Name: Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market (2025-2031) | Trends & Share
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By GLP-1 Receptor Agonists (Exenatide, Liraglutide (Victoza), Lixisenatide (Lyxumia), Dulaglutide (Trulicity), Semaglutide (Ozempic)), By Insulin Drugs (Basal or Long-acting Insulins, Bolus or Fast-acting Insulins, Traditional Human Insulins, Combination Insulins, Biosimilar Insulins) And Competitive Landscape

Product Code: ETC8432574	Publication Date: Sep 2024	Updated Date: Nov 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Mozambique Insulin Drugs and Glucagon-like Peptide 1 (Glp-1) Receptor Agonist Market: Top 5 Importing Countries and Market Competition (HHI) Analysis

The import shipments of insulin drugs and GLP-1 receptor agonists to Mozambique in 2024 were primarily sourced from India, South Africa, Portugal, the United States of America, and China. Despite the high Herfindahl-Hirschman Index indicating market concentration, the industry experienced a negative compound annual growth rate (CAGR) of -12.72% from 2020 to 2024. Furthermore, the growth rate plummeted to -40.22% in 2024 compared to the previous year. This data suggests a challenging landscape for the importation of these essential medications in Mozambique, potentially indicating shifts in market dynamics and demand trends.

Mozambique Insulin Drugs and Glucagon-like Peptide 1 (Glp-1) Receptor Agonist Market: Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Outlook
Market Size of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, 2024
Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Revenues & Volume for the Period 2021- 2031
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Trend Evolution
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Drivers and Challenges
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Price Trends
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Porter's Five Forces
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Industry Life Cycle
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By GLP-1 Receptor Agonists for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Exenatide for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Liraglutide (Victoza) for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Lixisenatide (Lyxumia) for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Dulaglutide (Trulicity) for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Semaglutide (Ozempic) for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Insulin Drugs for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Basal or Long-acting Insulins for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Bolus or Fast-acting Insulins for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Traditional Human Insulins for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Combination Insulins for the Period 2021- 2031
Historical Data and Forecast of Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume By Biosimilar Insulins for the Period 2021- 2031
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Import Export Trade Statistics
Market Opportunity Assessment By GLP-1 Receptor Agonists
Market Opportunity Assessment By Insulin Drugs
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Top Companies Market Share
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Competitive Benchmarking By Technical and Operational Parameters
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Company Profiles
Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Overview

3.1 Mozambique Country Macro Economic Indicators

3.2 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, 2021 & 2031F

3.3 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market - Industry Life Cycle

3.4 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market - Porter's Five Forces

3.5 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume Share, By GLP-1 Receptor Agonists, 2021 & 2031F

3.6 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume Share, By Insulin Drugs, 2021 & 2031F

4 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in Mozambique

4.2.2 Growing awareness about the importance of managing diabetes

4.2.3 Technological advancements in insulin drugs and GLP-1 receptor agonists

4.3 Market Restraints

4.3.1 High cost of insulin drugs and GLP-1 receptor agonists

4.3.2 Limited access to healthcare facilities in remote areas of Mozambique

4.3.3 Lack of skilled healthcare professionals for diabetes management

5 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Trends

6 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, By Types

6.1 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, By GLP-1 Receptor Agonists

6.1.1 Overview and Analysis

6.1.2 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By GLP-1 Receptor Agonists, 2021- 2031F

6.1.3 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Exenatide, 2021- 2031F

6.1.4 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Liraglutide (Victoza), 2021- 2031F

6.1.5 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Lixisenatide (Lyxumia), 2021- 2031F

6.1.6 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Dulaglutide (Trulicity), 2021- 2031F

6.1.7 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Semaglutide (Ozempic), 2021- 2031F

6.2 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market, By Insulin Drugs

6.2.1 Overview and Analysis

6.2.2 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Basal or Long-acting Insulins, 2021- 2031F

6.2.3 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Bolus or Fast-acting Insulins, 2021- 2031F

6.2.4 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Traditional Human Insulins, 2021- 2031F

6.2.5 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Combination Insulins, 2021- 2031F

6.2.6 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenues & Volume, By Biosimilar Insulins, 2021- 2031F

7 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Import-Export Trade Statistics

7.1 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Export to Major Countries

7.2 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Imports from Major Countries

8 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Key Performance Indicators

8.1 Percentage increase in diabetes screening rates

8.2 Adoption rate of new technologies for diabetes management

8.3 Number of diabetes education programs conducted in Mozambique

9 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market - Opportunity Assessment

9.1 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Opportunity Assessment, By GLP-1 Receptor Agonists, 2021 & 2031F

9.2 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Opportunity Assessment, By Insulin Drugs, 2021 & 2031F

10 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market - Competitive Landscape

10.1 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Revenue Share, By Companies, 2024

10.2 Mozambique Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Iran Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Ireland Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Israel Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Ivory Coast Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

Jamaica Insulin Drugs and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market